Galderma soothes ECM with 15% pop after Sfr2bn IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Equity
Equity IPOs

Galderma soothes ECM with 15% pop after Sfr2bn IPO

Aidan Gregory
March 22, 2024 12:44 PM
A logo sign outside of a facility occupied by Galderma in Baie-d?Urfe, Quebec, Canada, on April 21, 2019. (Photo by Kristoffer Tripplaar/Sipa USA)

The biggest IPO of 2024 so far in Europe has delivered a welcome bounce in the aftermarket

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsSwitzerlandGoldman SachsMorgan StanleyUBSCitiJefferies LLCBank of AmericaBNP ParibasHealth and Biotech
AG
Aidan Gregory
Gift this article